Have you or someone you know experienced or been affected by cystic fibrosis? Your input is needed on a review considering CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
Skills / interests: Patient and public input
Would you be interested in helping us with this research article focused on CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)?
I am looking for a patient or member of the public who would be willing to peer review this Cochrane systematic review, “CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)”.
When we say ‘patients and the public’, we mean patients and potential patients, carers, people who use health and social care services, and people or organizations that represent these groups.
We are interested in whether the language of the review, especially the language used in the Plain Language Summary (PLS), is accessible and feels relevant for those experiencing cystic fibrosis, so it will be helpful to patients and members of the public making healthcare decisions.
We welcome feedback on any aspect of the review, with particular focus on the PLS section. Our aim is for this to be a manageable task and not overburden our reviewers.
If you are interested in providing peer review, please include your e-mail address in your response. This will allow us to confirm your enrolment in our editorial management system (called Editorial Manager) and ensure that you can receive the review assignment.
Thank you in advance for your consideration!
Cochrane